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Background: Merkel cell carcinoma is a rare and aggressive skin malignancy that arises from primary neural cells
and has a tendency for local recurrence and regional lymph node metastases. There are only a few cases in the
literature reporting metastases of Merkel cell carcinoma to the gastrointestinal tract.
Case presentation: We present a 70 year old Caucasian female with distant history of Merkel cell carcinoma who
presented with iron-deficiency anemia. Colonoscopy performed later for the evaluation of anemia revealed 1 cm
polyp in ascending colon which turned out to be the recurrence of Merkel cell carcinoma.
Conclusion: Metastatic Merkel cell carcinoma to the gastrointestinal tract or any other organ should be considered
in patients with a history of Merkel cell carcinoma.
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Merkel cell carcinoma (MCC) is a rare condition. Earlier
studies suggested that MCC originates from Merkel cells
[1] which are mechanoreceptors located at stratum
basale of the epidermis [2]. However, MCC probably
arises from some kind of progenitor cell of the skin as
substantial differences exist between MCC and Merkel
cells [3]. Clinically, patients with MCC typically present
with a rapidly growing, painless, firm, nontender, shiny,
flesh-colored or bluish-red, intracutaneous nodule [1,4].
After resection, local recurrence is common but a review
of the literature found only a few cases of documented
metastases to gastrointestinal (GI) tract [4]. We present
a case of Merkel cell carcinoma of the skin that recurred
in the colon.
Case Presentation
A 70-year-old Caucasian female was evaluated for a one
month history of progressively worsening low back pain
and weakness. She had no gastrointestinal tract com-
plaints. Her past medical history was significant for mul-
tiple basal and squamous cell cancers, as well as Merkel
cell carcinoma 5 years previously, at which time she pre-
sented with a lump in her left groin. After local resection,* Correspondence: rasikh.tuktamyshov@ynhh.org
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unless otherwise stated.she was treated with radiation and carboplatin. There was
no recurrence and a subsequent abdominal CT (computed
tomography) scan 3 years later showed no evidence of
metastatic disease. The primary site was thought to be an
inguinal lymph node.
On physical exam she had a 5 mm mobile lymph node
in the left supraclavicular area. There were no focal neuro-
logical deficits. Stool tested guaiac negative. Labs revealed
hemoglobin 7.1 g/dL, hematocrit 21.1%, iron level 15
mcg/dL, total iron binding capacity 330 mg/dL, and trans-
ferrin saturation 5%, consistent with severe iron-deficiency
anemia. A contrast enhanced abdominal CT scan showed
bulky retroperitoneal adenopathy encompassing the renal
arteries, aorta, inferior vena cava as well as circumferen-
tially thickened loop of small bowel in the left hemiabdo-
men (Figure 1). A small bowel series was negative. The
decision was made to perform a colonoscopy.
The findings at colonoscopy (Figure 2) revealed a
semi-sessile ascending colon polyp measuring approxi-
mately 1 cm in size. The polyp was smooth and pale,
with regular margins, and normal surrounding mucosa.
It was resected as a single piece using hot snare poly-
pectomy technique, and all tissue was recovered into a
sterile trap and submitted for routine histology. Post-
resection appearances suggested complete removal of all
polypoid mucosa. Pathological examination of the speci-
men showed a small blue cell neoplasm involving bothentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 CT scan. Extensive bulky retroperitoneal lymphadenopathy
(lymph node of 35.4 mm is marked on the picture).
Figure 3 Low magnification photograph showing the tumor
infiltrating into the submucosa as well as overlying mucosa. The
tumor cells are diffusely infiltrating the tissues without any specific
arrangement or pattern.
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tumor cells were relatively small with scanty cytoplasm
and hyperchromatic round nuclei. Immunostain for cyto-
keratin 20 showing perinuclear dot like cytoplasmic and
surface positivity. Immunostaining for endocrine markers
chromogranin and synaptophysin showed strong cytoplas-
mic positivity. The findings are typical of MCC and were
similar to the patient’s previous groin tumor. The patient
was diagnosed with stage IV MCC based on the presence
of a distant metastasis.
The patient was treated with 4 cycles of cisplatin and
etoposide (VP-16). Five months later, a CT of the abdo-
men showed increase in abdominal lymphadenopathy and
a midjejunal small bowel mass that was felt to represent a
metastatic focus. She received an additional 8 cycles of
chemotherapy with cyclophosphamide, doxorubicin andFigure 2 Colonoscopy, 10 mm sessile polyp.vincristine and a follow-up positron emission tomography
scan showed resolution of the previous multifocal lymph-
adenopathy in the chest, abdomen, and pelvis with no new
lesions.
Discussion
Merkel cell cancer is a rare skin malignancy. In the Sur-
veillance, Epidemiology, and End Results (SEER) database
a total of 1665 cases were identified between 1973 and
2002 [5]. The cause is unknown. Sunlight has been impli-
cated as a causative factor, in view of its predilection for
sun-exposed regions of the body and geographic distribu-
tion [1,2]. In one prospective study, the highest age ad-
justed incidence among a Caucasian population was in
Hawaii, the geographic location with the highest ultravio-
let B index [6]. Immunosuppression has been associated
with MCC, and linked with organ transplantation [7].Figure 4 Higher magnification to show tumor cells that are small
with hyperchromatic nuclei and scanty cytoplasm.
Figure 5 Immunostain for cytokeratin 20 showing diffuse
cytoplasmic and surface positivity.
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immunosuppressing medications like tumor necrosis fac-
tor inhibitors, including etanercept (Enbrel®) [8] and adali-
mumab (Humira®) [9]. In 2008, a previously unknown
polyomavirus was detected in 80% of patients with MCC
in a series of 10 patients, suggesting a possible role in the
pathogenesis [10].
On light microscopy MCC may be confused with
poorly differentiated small-cell tumors such as small-cell
lung cancer, lymphoma, neuroblastoma and other “small
round blue cell tumors”, which are characterized by a
superficially very blue appearance on routine H & E
stained sections due to the cells having a single large
hyperchromatic nucleus with evenly distributed granular
chromatin and a thin rim of cytoplasm [11]. This ap-
pearance is shared by many tumors including small cell
carcinoma, lymphoma, Ewing sarcoma and rhabdomyo-
sarcoma, amongst others. The pathologic differentialFigure 6 Immunostain for endocrine markers chromogranin
and synaptophysin were similar and showed strong cytoplasmic
positivity.diagnosis of Merkel cell carcinoma includes other small
round blue cell tumors, particularly lymphoma and small
cell carcinoma when encountered in the GI tract. The im-
munohistochemical profile of the tumor is very typical
with perinuclear punctate or dot-like positivity for CK20
(cytokeratin 20) and endocrine markers. This is in contrast
to small cell carcinomas which, although frequently posi-
tive for endocrine markers, are negative for CK20. The
small cells carcinomas in addition often show positivity of
TTF-1 (thyroid transcription factor-1) or less commonly
CDX-2 (caudal homeobox 2 protein) in the GI tract.
Lymphomas can be easily differentiated by positivity for
various leukocyte markers and lack of keratins and endo-
crine markers.
Our case report presents a patient with MCC metastatic
to colon. The jejunal mass and lymphadenopathy seen on
the initial abdominal CT before the colonoscopy were
most likely metastasis of MCC but not confirmed by tissue
biopsy. The patient responded well to chemotherapy.
The patient in our case had nodal disease without an ap-
parent primary site, and this was the case for about 2% of
initial presentations out of 661 cases published by Tai
et al. [12]. The patient also had previous basal and squa-
mous cell carcinomas of the skin. The risk of development
of MCC is increased in patients with other malignancies
including skin cancers and melanoma. Moreover, MCC is
a risk factor for development of another primary cancer
with the highest risk for salivary gland tumors, bladder
cancer, and multiple myeloma [13].
There are only a few cases in the literature reporting
MCC metastases to the GI tract [14-19] and only three
cases to our knowledge with metastasis to the large in-
testine. One of them describes a case with metastases to
the colon, duodenum and stomach 6 years after the exci-
sion of a skin lesion on the neck that was initially diag-
nosed as basal cell carcinoma but reevaluation of the
specimen confirmed MCC [14]. The second one reports
the case of a patient who presented with hematochezia
from MCC in the rectum [15]. A third case reports pri-
mary head and neck MCC with metastasis to the colon
who survived for 6 years [16].
There are more cases that report MCC metastatic to
other parts of GI tract. One of them describes a patient
with acute upper GI bleeding from a gastric metastasis
[17]. Krasagakis s. presented the case of a patient who
had widely spread metastatic disease including the stom-
ach [18]. Another case presented the recurrence of
MCC at ileocecal valve 18 months after resection of a
tumor on the neck [19].
Conclusion
MCC is a rare disease that rarely metastasizes to the
gastrointestinal tract and may mimic other small blue
round cell tumors. The morphology combined with
Tuktamyshov et al. BMC Research Notes  (2015) 8:188 Page 4 of 4immunostaining profile helps to establish the correct
diagnosis. Metastatic disease should be in the differential
diagnosis when evaluating GI symptoms in a patient
with a history of MCC.
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